Synthesis and evaluation of ortho-[¹⁸F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging

References

• HayashiNYamamotoHHiraokaNDifferential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasmHepatology200134463865011584358
   PubMed Web of Science ®Google Scholar
• SiricaAELaiGHZhangZCBiliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategiesJ Gastroenterol Hepatol200116436337211357901
   PubMed Web of Science ®Google Scholar
• SiricaAELaiGHEndoKZhangZCYoonBICyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targetsSemin Liver Dis200222330331312360423
   PubMed Web of Science ®Google Scholar
• MarksEIYeeNSMolecular genetics and targeted therapeutics in biliary tract carcinomaWorld J Gastroenterol20162241335134726819503
   PubMed Web of Science ®Google Scholar
• BridgewaterJGallePRKhanSAGuidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJ Hepatol20146061268128924681130
   PubMed Web of Science ®Google Scholar
• Taylor-RobinsonSDToledanoMBAroraSIncrease in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998Gut200148681682011358902
   PubMed Web of Science ®Google Scholar
• KhanSATaylor-RobinsonSDToledanoMBBeckAElliottPThomasHCChanging international trends in mortality rates for liver, biliary and pancreatic tumoursJ Hepatol200237680681312445422
   PubMed Web of Science ®Google Scholar
• CasavillaFAMarshJWIwatsukiSHepatic resection and transplantation for peripheral cholangiocarcinomaJ Am Coll Surg199718554294369358085
   PubMed Web of Science ®Google Scholar
• OhtsukaMItoHKimuraFResults of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survivalBr J Surg200289121525153112445060
   PubMed Web of Science ®Google Scholar
• SmithWLUradeYJakobssonPJEnzymes of the cyclooxygenase pathways of prostanoid biosynthesisChem Rev2011111105821586521942677
   PubMed Web of Science ®Google Scholar
• KhanSADavidsonBRGoldinRDGuidelines for the diagnosis and treatment of cholangiocarcinoma: an updateGut201261121657166922895392
   PubMed Web of Science ®Google Scholar
• SiricaAECholangiocarcinoma: molecular targeting strategies for chemoprevention and therapyHepatology200541151515690474
   PubMed Web of Science ®Google Scholar
• BerthiaumeEPWandsJThe molecular pathogenesis of cholangiocarcinomaSemin Liver Dis200424212713715192786
   PubMed Web of Science ®Google Scholar
• BurrNETalboysRJSavvaSAspirin may prevent cholangiocarcinoma: a case-control study from the United KingdomDigest Dis Sci20145971567157224535250
   PubMed Web of Science ®Google Scholar
• JendrossekVTargeting apoptosis pathways by Celecoxib in cancerCancer Lett2013332231332421345578
   PubMed Web of Science ®Google Scholar
• PreshlockSTredwellMGouverneurVF-18-labeling of arenes and heteroarenes for applications in positron emission tomographyChem Rev2016116271976626751274
   PubMed Web of Science ®Google Scholar
• PrabhakaranJUnderwoodMDParseyRVSynthesis and in vivo evaluation of F-18 -4- 5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl benzene sulfonamide as a PET imaging probe for COX-2 expressionBioorg Med Chem20071541802180717166726
   PubMed Web of Science ®Google Scholar
• ToyokuniTKumarJSDWalshJCSynthesis of 4-(5-F-18 fluoromethyl-3-phenylisoxazol-4-yl)-benzenesulfonamide, a new F-18 fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomographyBioorg Med Chem Lett200515214699470216153836
   PubMed Web of Science ®Google Scholar
• UddinMJCrewsBCGhebreselasieKFluorinated COX-2 Inhibitors as Agents in PET Imaging of Inflammation and CancerCancer Prev Res201141015361545
   PubMed Web of Science ®Google Scholar
• RieseJHoffTNordhoffADewittDLReschKKaeverVTransient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activationJ Leukoc Biol19945544764828145018
   PubMed Web of Science ®Google Scholar
• McCarthyTJSheriffAUGranetoMJTalleyJJWelchMJRadio-synthesis, in vitro validation, and in vivo evaluation of F-18-labeled COX-1 and COX-2 inhibitorsJ Nucl Med200243111712411801714
   PubMed Web of Science ®Google Scholar
• de VriesEFJvan WaardeABuursmaARVaalburgWSynthesis and in vivo evaluation of F-18-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expressionJ Nucl Med200344101700170614530489
   PubMed Web of Science ®Google Scholar
• RiniBIWeinbergVDunlapSMaximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinomaCancer2006106356657516369983
   PubMed Web of Science ®Google Scholar
• FabiAMetroGPapaldoPImpact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a Phase II study with biomarker evaluationCancer Chemother Pharmacol200862471772518071704
   PubMed Web of Science ®Google Scholar
• JewettDMPotockiJFEhrenkauferREA gas solid-phase microchemical method for the synthesis of acetyl hypofluoriteJ Fluorine Chem1984244477484
   Web of Science ®Google Scholar
• BiavaMPorrettaGCPoceGCyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivityJ Med Chem200750225403541117915854
   PubMed Web of Science ®Google Scholar
• HusainAAhmadAAlamMMAjmalMAhujaPFenbufen based 3- 5-(substituted aryl)-1,3,4-oxadiazol-2-yl -1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agentsEur J Med Chem20094493798380419457595
   PubMed Web of Science ®Google Scholar
• HoodWFGierseJKIsaksonPCCharacterization of celecoxib and valdecoxib binding to cyclooxygenaseMol Pharmacol200363487087712644588
   PubMed Web of Science ®Google Scholar
• GierseJKZhangYHoodWFValdecoxib: assessment of cyclooxygenase-2 potency and selectivityJ Pharmacol Exp Ther200531231206121215494548
   PubMed Web of Science ®Google Scholar
• HuangHLYehCNLeeWYI-123 Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymesBiomaterials201334133355336523384791
   PubMed Web of Science ®Google Scholar
• HuangHLHuangYCLeeWYYehCNLinKJYuCSF-18-gluta-thione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzymePLoS One20149814
   Web of Science ®Google Scholar
• YehCNChangCWChungYHSynthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinomaEur J Pharm Sci201710721722928728977
   PubMed Web of Science ®Google Scholar
• YehCNLinKJChenTWCharacterization of a novel rat cholangiocarcinoma cell culture model-CGCCAWorld J Gastroenterol201117242924293221734803
   PubMed Web of Science ®Google Scholar
• ChenSFWuCHLeeYMCaveolin-1 interacts with derlin-1 and promotes ubiquitination and degradation of cyclooxygenase-2 via collaboration with p97 complexJ Biol Chem201328846334623346924089527
   PubMed Web of Science ®Google Scholar
• YehCNMaitraALeeKFJanYYChenMFThioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinomaCarcinogenesis200425463163614656942
   PubMed Web of Science ®Google Scholar
• MonakhovNKNeistadtELShavlovskilMMShvartsmanALNeifakhSAPhysicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissuesJ Natl Cancer Inst19786112734276635
   PubMedGoogle Scholar
• LiZBCaiWBCaoQZ64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expressionJ Nucl Med20074871162117117574975
   PubMed Web of Science ®Google Scholar
• JacobsonOWeissIDKiesewetterDOFarberJMChenXYPET of tumor CXCR4 expression with 4-F-18-T140J Nucl Med201051111796180420956475
   PubMed Web of Science ®Google Scholar
• TietzOWuestMMarshallAPET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer modelEJNMMI Res201661126860293
   PubMed Web of Science ®Google Scholar
• WeberACasiniAHeineAUnexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognitionJ Med Chem200447355055714736236
   PubMed Web of Science ®Google Scholar
• ChungYHHsuPHHuangCWEvaluation of prognostic integrin alpha 2 beta 1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detectionMol Pharm201411113904391425153169
   PubMed Web of Science ®Google Scholar